INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL OF THE AMERICAS (EIN 521732704) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1991

Legal Domicile

Principal Officer

KIM BEALS

Phone

5718143451

Tax Period

2024-01-01 to 2024-12-31

INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL OF THE AMERICAS, founded in 1991, is a community nonprofit that reported $1.0M in total revenue in fiscal year 2018. Revenue decreased 15% compared to the prior year.

Mission

TO DEVELOP, IMPLEMENT AND PROMOTE VOLUNTARY GUIDANCE AND OTHER PROGRAMS FOR THE WORLD PHARMACEUTICAL INDUSTRY THAT ARE DESIGNED TO ENSURE THAT EXCIPIENTS AND RELATED COMPONENTS IN FINISHED DRUG PRODUCTS MEET ONLY THE HIGHEST APPROPRIATE STANDARDS FOR QUALITY, SAFETY, AND FUNCTIONALITY THROUGHOUT THEIR MANUFACTURING PROCESS; AND TO ENCOURAGE AND ASSIST THE ADOPTION OF SCIENTIFICALLY SUITABLE AND VALID REGULATORY AND COMPENDIAL STANDARDS FOR PHARMACEUTICAL EXCIPIENTS.

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $1,482,767

Investment Income $33,351

Other Revenue $12,307

TOTAL REVENUE $1,528,425

Expense Breakdown

Grants Paid $45,140

Salaries & Benefits $511,522

Fundraising Expenses $0

Program Expenses $1,514,307

Other Expenses $1,161,474

TOTAL EXPENSES $1,718,136

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,528,425	$1,404,333	+0.1%
Expenses	$1,718,136	$1,537,299	+0.1%
Net Income	$-189,711	$-132,966	+0.4%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$196,001

Total Directors

$196,001

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
KIM BEALS	SEC/TREASURER	40.00	Officer Director	$196,001	$0	$196,001
JANEEN SKUTNIK-WILKINSON	Director	1.00	Director	$0	$0	$0
PRISCILLA ZAWISLAK	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
MIKE CASSELL	Director	1.00	Director	$0	$0	$0
CHARLOTTE MCLLVAINE	VICE CHAIR	1.00	Officer Director	$0	$0	$0
GEORGE COLLINS	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
NIGEL LANGLEY	IMM PAST CHAIR	1.00	Director	$0	$0	$0
JOSEPH ZELEZNIK	Chairman	1.00	Officer Director	$0	$0	$0
DOUGLAS MUSE	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
GINA MARSEE	CHAIR-ELECT	1.00	Director	$0	$0	$0
MEERA RAGHURAM	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
JENNIFER PUTNAM	VICE-CHAIR	1.00	Officer Director	$0	$0	$0
TROY BARRIX	Director	1.00	Director	$0	$0	$0
TERESA WEGESSER	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,528,425	$1,718,136	$1,903,547	$-189,711
2023	$1,404,333	$1,537,299	$1,826,612	$-132,966
2022	$1,449,076	$1,538,026	$2,041,325	$-88,950
2021	$1,112,656	$1,069,780	$2,227,732	$42,876
2020	$1,025,233	$1,088,556	$1,917,327	$-63,323
2019	$1,221,153	$1,241,094	$2,015,771	$-19,941
2018	$1,017,731	$1,080,967	$1,806,980	$-63,236

INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL OF THE AMERICAS